Literature DB >> 2846225

Age does not alter human vascular and nonvascular beta 2-adrenergic responses to isoproterenol.

C Klein1, W R Hiatt, J G Gerber, A S Nies.   

Abstract

beta-Adrenoceptor-mediated functions appear to diminish with aging, but the exact scope of these changes is unknown, because most studies have been limited to beta 1-adrenergic cardiac phenomena. To evaluate both a vascular and a nonvascular beta 2-adrenergic response in the aged, we have studied 12 healthy elderly and 12 healthy young subjects infused with increasing doses of isoproterenol and compared the change in peripheral vascular resistance, measured by venous occlusion plethysmography, and insulin release. In both groups vascular resistance fell and insulin concentrations increased. These changes were equivalent in both groups, and we therefore infer no significant decline in either of these beta 2-adrenergic functions in the elderly.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846225     DOI: 10.1038/clpt.1988.196

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  8 in total

Review 1.  Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.

Authors:  Arduino A Mangoni
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Beta-adrenoceptor responses to inhaled salbutamol in the elderly.

Authors:  B J Lipworth; B F Tregaskis; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

3.  Insulin responses to glucose and isoproterenol decrease with age.

Authors:  James M Watters
Journal:  Can J Surg       Date:  2005-04       Impact factor: 2.089

4.  β-Adrenergic receptor blockade impairs coronary exercise hyperemia in young men but not older men.

Authors:  Amanda J Ross; Zhaohui Gao; Jonathan P Pollock; Urs A Leuenberger; Lawrence I Sinoway; Matthew D Muller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-19       Impact factor: 4.733

Review 5.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

6.  Evidence for agonist-specific endothelial vasodilator dysfunction with ageing in healthy humans.

Authors:  Christopher A DeSouza; Christopher M Clevenger; Jared J Greiner; Derek T Smith; Greta L Hoetzer; Linda F Shapiro; Brian L Stauffer
Journal:  J Physiol       Date:  2002-07-01       Impact factor: 5.182

Review 7.  The epidemiology and therapy of airflow limitation in the elderly.

Authors:  L Dow
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

Review 8.  Clinical pharmacokinetics of beta-agonists.

Authors:  D J Morgan
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.